Expanding the prescription cannabis market will lead to improved outcomes for ethnic minorities, women, and the LGBT community, according to a new report from the Cannabis Industry Council (CIC).
With an eye on limitless integration and client satisfaction, Cannavigia’s open API is the next stride towards enriched operational efficiency
BZAM Ltd. (the “Company” or “BZAM”) (CSE: BZAM) (US-OTC:BZAMF), is pleased to announce that its subsidiary, The Green Organic Dutchman
PHCANN International has appointed Mr. Sasho Stefanoski as the new Chief Executive Officer (CEO) of the Group. PHCANN International is
Ananda Developments plc (AQSE: ANA)and its wholly owned subsidiary DJT Plants Limited (“DJT”) have signed a Memorandum of Understanding (“MOU”)
Canndr® Debuts at The 2023 UK Medicinal Cannabis Awareness Week, the patient-centric platform powered by patients who deserve clarity, information
Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased
November 01 this year marks five years since the UK government legalised cannabis-based products for medicinal use in 2018 and
Cantourage Group SE (hereinafter “Cantourage,” ISIN: DE000A3DSV01, www.cantourage.com), a leading European company for the production and distribution of medical cannabis,
A draft Bill to enable general medical practitioners (GPs) to prescribe cannabis medicines has been published by the Cannabis Industry
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.